| Depressive symptom category |  | |||
---|---|---|---|---|---|
 | None n = 248 | Baseline only n = 32 | New onset n = 28 | Persistent n = 42 | P-value* |
Sociodemographic and Lifestyle Factors | |||||
 Age: mean (SD) | 70.1 (5.8) | 71.0 (6.1) | 74.3 (6.5) | 71.7 (5.3) | 0.03 |
 Age 75+: n (%) | 57 (23.0) | 7 (21.9) | 9 (32.1) | 12 (28.6) | 0.11 |
 Male: n (%) | 186 (75.0) | 23 (71.9) | 18 (64.3) | 31 (73.8) | 0.67 |
 Education: mean (SD), y | 13.2 (3.8) | 11.5 (2.7) | 11.4 (4.3) | 12.2 (4.2) | 0.01 |
 Lives alone: n (%) | 31 (12.5) | 8 (25.0) | 9 (32.1) | 7 (16.7) | 0.02 |
 Current or past smoker: n (%) | 176 (71.0) | 23 (71.9) | 20 (71.4) | 30 (71.4) | >0.99 |
 Heavy drinker: n (%) | 48 (19.4) | 8 (25.0) | 4 (14.3) | 8 (19.0) | 0.77 |
Treatment Group, n (%) | |||||
 CABG | 80 (32.3) | 13 (40.6) | 10 (35.7) | 18 (42.9) | 0.66 |
 PCI | 107 (43.1) | 13 (40.6) | 9 (32.1) | 14 (33.3) |  |
 Medical Therapy | 61 (24.6) | 6 (18.8) | 9 (32.1) | 10 (23.8) |  |
Clinical Characteristicsa n (%) | |||||
 Admitted with stable angina (vs MI, unstable angina and other) | 168 (68.3) | 19 (61.3) | 16 (57.1) | 24 (57.1) | 0.37 |
 Ejection Fraction <50 % | 53 (21.5) | 9 (29.0) | 6 (21.4) | 9 (21.4) | 0.82 |
 High risk coronary anatomyb | 105 (42.7) | 19 (61.3) | 16 (59.3) | 20 (48.8) | 0.17 |
 CCS angina class > II | 104 (42.3) | 19 (61.3) | 18 (64.3) | 26 (61.9) | 0.01 |
 Acute coronary syndrome | 53 (21.5) | 9 (29.0) | 11 (39.3) | 16 (38.1) | 0.04 |
Medical Historya n (%) | |||||
 Cerebrovascular disease | 20 (8.1) | 4 (12.9) | 2 (7.1) | 8 (19.0) | 0.14 |
 Congestive heart failure | 22 (8.9) | 3 (9.7) | 5 (17.9) | 3 (7.1) | 0.45 |
 Peripheral vascular diseasec | 21 (8.6) | 2 (6.3) | 1 (3.6) | 7 (16.7) | 0.57 |
 Diabetes Mellitus (Type I or II) | 52 (21.1) | 11 (35.5) | 4 (14.3) | 15 (35.7) | 0.05 |
 Hypertension | 185 (75.2) | 27 (87.1) | 23 (82.1) | 33 (78.6) | 0.44 |
 Hyperlipidemia | 207 (84.1) | 24 (77.4) | 25 (89.3) | 34 (81.0) | 0.62 |
 Pulmonary disease | 48 (19.5) | 7 (22.6) | 8 (28.6) | 13 (31.0) | 0.31 |
 Renal disease | 5 (2.0) | 2 (6.5) | 1 (3.6) | 2 (4.8) | 0.45 |
 Malignancy | 12 (4.9) | 1 (3.2) | 2 (7.1) | 3 (7.1) | 0.84 |
 Severe/debilitating liver disease | 1 (0.4) | 1 (3.2) | 0 (0) | 0 (0) | 0.23 |
 Severe/debilitating gastrointestinal disease | 14 (5.7) | 3 (9.7) | 2 (7.1) | 7 (16.7) | 0.09 |
Additional Clinical Information | |||||
 Baseline mean MMSE score (SD) | 28.5 (1.3) | 27.8 (2.0) | 27.6 (2.3) | 27.2 (2.6) | <0.001 |
 Previous stroke and/or TIA: n(%) | 27 (10.9) | 4 (12.5) | 5 (17.9) | 7 (16.7) | 0.57 |
 Self rated health-fair/poor: n(%)d | 34 (13.8) | 16 (50.0) | 7 (25.0) | 23 (54.8) | <0.001 |
 Anxiety level (STAI score): mean (SD)e | 32.7 (9.7) | 35.1 (9.2) | 35.2 (10.2) | 43.1 (10.2) | <0.001 |
Baseline and Follow-up GDS Score | |||||
 Baseline GDS scores, mean (SD) | 1.76 (1.28) | 6.22 (1.64) | 2.39 (1.37) | 7.60 (2.67) | <0.001 |
 6 Month GDS scores, mean (SD) | 1.12 (1.18) | 2.35 (1.33) | 5.61 (2.96) | 7.19 (3.05) | <0.001 |
 12 Month GDS scores, mean (SD) | 1.18 (1.22) | 1.78 (1.24) | 4.26 (2.86) | 6.90 (3.26) | <0.001 |
 30 month GDS scores, mean (SD) | 1.20 (1.46) | 3.11 (2.25) | 3.41 (2.89) | 7.70 (3.70) | <0.001 |